Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Autoinducer-2 (AI-2) quorum sensing receptor complex is a pivotal molecular assembly responsible for detecting and responding to interspecies signaling molecules in a broad spectrum of bacteria. AI-2, synthesized by the LuxS enzyme, serves as a universal language that allows both Gram-negative and Gram-positive bacteria to monitor population density and synchronize collective behaviors. The architecture of the receptor complex is species-dependent; for instance, in Vibrio species, it comprises the periplasmic binding protein LuxP and the sensor kinase LuxQ, whereas in Salmonella and Escherichia coli, the LsrB protein facilitates AI-2 internalization via an ABC transporter. Activation of these receptors triggers signaling cascades that regulate the expression of genes involved in virulence, biofilm formation, and antibiotic resistance. Consequently, the AI-2 receptor complex has emerged as a significant therapeutic target for the development of quorum-quenching agents, such as cinnamaldehyde and brominated furanones, which aim to attenuate bacterial pathogenicity without killing the microbes. This approach potentially reduces the selective pressure for antibiotic resistance and offers a novel strategy for managing complex, multi-species infections and biofilm-related diseases.
Competitive or non-competitive inhibition of AI-2 binding to periplasmic receptors (LuxP or LsrB), or modulation of the sensor kinase (LuxQ) activity to disrupt downstream quorum sensing signaling and gene expression.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Autoinducer-2 quorum sensing receptor complex (AI-2 receptor complex).